ATE143259T1 - Verfahren zum hervorheben von prägungen in tabletten - Google Patents

Verfahren zum hervorheben von prägungen in tabletten

Info

Publication number
ATE143259T1
ATE143259T1 AT92904760T AT92904760T ATE143259T1 AT E143259 T1 ATE143259 T1 AT E143259T1 AT 92904760 T AT92904760 T AT 92904760T AT 92904760 T AT92904760 T AT 92904760T AT E143259 T1 ATE143259 T1 AT E143259T1
Authority
AT
Austria
Prior art keywords
tablets
highlighting
embossings
solvent
filling material
Prior art date
Application number
AT92904760T
Other languages
English (en)
Inventor
Paul M V Gilis
Conde Valentin F V De
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE143259T1 publication Critical patent/ATE143259T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Cosmetics (AREA)
  • Paper (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Color Printing (AREA)
AT92904760T 1991-02-27 1992-02-14 Verfahren zum hervorheben von prägungen in tabletten ATE143259T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91200417 1991-02-27

Publications (1)

Publication Number Publication Date
ATE143259T1 true ATE143259T1 (de) 1996-10-15

Family

ID=8207528

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92904760T ATE143259T1 (de) 1991-02-27 1992-02-14 Verfahren zum hervorheben von prägungen in tabletten

Country Status (16)

Country Link
US (1) US5405642A (de)
EP (2) EP0573462B1 (de)
JP (1) JP3237758B2 (de)
AT (1) ATE143259T1 (de)
AU (1) AU1260392A (de)
CA (1) CA2104096C (de)
DE (1) DE69214130T2 (de)
DK (1) DK0573462T3 (de)
ES (1) ES2094902T3 (de)
GR (1) GR3021929T3 (de)
IE (1) IE75729B1 (de)
MX (1) MX9200831A (de)
NZ (1) NZ241613A (de)
TW (1) TW201697B (de)
WO (1) WO1992015288A1 (de)
ZA (1) ZA921428B (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6113945A (en) * 1996-02-26 2000-09-05 L. Perrigo Company Multi-colored medicament
US5827535A (en) * 1996-06-21 1998-10-27 Banner Pharmacaps, Inc. Graphically impressed softgel and method for making same
DE69702985T2 (de) 1997-09-23 2001-02-15 Akzo Nobel N.V., Arnheim/Arnhem Steroid enthaltende Dosierungsformen mit einer steroiddichten Umhüllung
US6685961B1 (en) 2000-10-24 2004-02-03 Banner Pharmacaps, Inc. Colored gelatin-based formulations and method
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
GB0110846D0 (en) * 2001-05-02 2001-06-27 Phoqus Ltd Tablets with coloured patterns
US7183410B2 (en) * 2001-08-02 2007-02-27 Bidachem S.P.A. Stable polymorph of flibanserin
US20030060475A1 (en) * 2001-08-10 2003-03-27 Boehringer Ingelheim Pharma Kg Method of using flibanserin for neuroprotection
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
WO2003026626A2 (en) * 2001-09-28 2003-04-03 Mcneil-Ppc, Inc. Modified release dosage forms
US6837696B2 (en) * 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US20040048877A1 (en) * 2002-05-22 2004-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions containing flibanserin
DE60315857T2 (de) * 2002-06-26 2008-05-21 Mars Inc. Essbare tinten für tintenstrahldruck auf essbaren substraten
US7029112B2 (en) 2002-08-05 2006-04-18 Mars, Incorporated Ink-jet printing on surface modified edibles and products made
US7807197B2 (en) * 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US7906167B2 (en) 2003-03-07 2011-03-15 Mars Incorporated Water based inks for printing on confectionery
US20050074514A1 (en) * 2003-10-02 2005-04-07 Anderson Oliver B. Zero cycle molding systems, methods and apparatuses for manufacturing dosage forms
US20050239798A1 (en) * 2004-04-22 2005-10-27 Boehringer Ingelheim Pharmaceuticals, Inc. Method for the treatment of premenstrual and other female sexual disorders
MXPA06012059A (es) * 2004-04-22 2007-01-25 Boehringer Ingelheim Int Nuevas composiciones farmaceuticas para el tratamiento de los trastornos sexuales ii.
US20060025420A1 (en) * 2004-07-30 2006-02-02 Boehringer Ingelheimn International GmbH Pharmaceutical compositions for the treatment of female sexual disorders
EP1789048A1 (de) * 2004-09-03 2007-05-30 Boehringer Ingelheim International GmbH Verfahren zur behandlung von aufmerksamkeitsdefizitstörung mit hyperaktivität
US20060088587A1 (en) * 2004-10-27 2006-04-27 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20070190133A1 (en) * 2004-10-27 2007-08-16 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US8383159B2 (en) * 2004-10-27 2013-02-26 Mcneil-Ppc, Inc. Dosage forms having a microreliefed surface and methods and apparatus for their production
US20060088586A1 (en) * 2004-10-27 2006-04-27 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20060087051A1 (en) * 2004-10-27 2006-04-27 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20060088593A1 (en) * 2004-10-27 2006-04-27 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20070281022A1 (en) * 2004-10-27 2007-12-06 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20060199805A1 (en) * 2005-03-04 2006-09-07 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
EP1858516A1 (de) * 2005-03-04 2007-11-28 Boehringer Ingelheim International GmbH Pharmazeutische zusammensetzungen zur behandlung und/oder verhinderung von depressionen
WO2006096439A2 (en) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
US8673352B2 (en) * 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
EP1904182A2 (de) * 2005-05-06 2008-04-02 Boehringer Ingelheim International GmbH Verfahren zur behandlung von drogenmissbrauch mit flibanserin
CA2608363A1 (en) * 2005-05-19 2006-11-23 Boehringer Ingelheim International Gmbh Method for the treatment of drug-induced sexual dysfunction
JP2008540672A (ja) * 2005-05-19 2008-11-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 病状に起因する性的機能不全の治療方法
US8227476B2 (en) 2005-08-03 2012-07-24 Sprout Pharmaceuticals, Inc. Use of flibanserin in the treatment of obesity
US7827911B2 (en) * 2005-09-22 2010-11-09 Bpsi Holdings, Inc. Method for printing on tablets
US20070123540A1 (en) * 2005-10-29 2007-05-31 Angelo Ceci Sexual desire enhancing medicaments comprising benzimidazolone derivatives
CA2626134C (en) * 2005-10-29 2013-12-24 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
US20070105869A1 (en) * 2005-11-08 2007-05-10 Stephane Pollentier Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
JP2009536176A (ja) * 2006-05-09 2009-10-08 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 閉経後の性的欲求障害の治療のためのフリバンセリンの使用
US20090312242A1 (en) * 2006-06-30 2009-12-17 Ramiro Castro Flibanserin for the treatment of urinary incontinence and related diseases
US20090318469A1 (en) * 2006-07-14 2009-12-24 Boehringer Ingelheim International Gmbh Use of Flibanserin for the Treatment of Sexual Disorders in Females
CL2007002214A1 (es) * 2006-08-14 2008-03-07 Boehringer Ingelheim Int Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
CA2660476C (en) * 2006-08-14 2015-11-17 Boehringer Ingelheim International Gmbh Formulations of flibanserin and method for manufacturing the same
EP2056797A2 (de) * 2006-08-25 2009-05-13 Boehringer Ingelheim International GmbH System mit kontrollierter freisetzung und verfahren zu seiner herstellung
PE20091188A1 (es) * 2007-09-12 2009-08-31 Boehringer Ingelheim Int Compuesto 1-[2-(4-(3-trifluorometil-fenil)piperazin-1-il)etil]-2,3-dihidro-1h-benzimidazol-2-ona (flibanserina), sus sales de adicion y composiciones farmaceuticas que los contienen

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3125490A (en) * 1964-03-17 Tablet with contrasting indicia and method
US3436453A (en) * 1963-06-14 1969-04-01 American Cyanamid Co Surface dyed edible gelatin capsule with pigment marking
FR1426194A (fr) * 1964-10-20 1966-01-28 Ile De France Nouvelle technique d'enrobage des comprimés
US3539380A (en) * 1968-01-08 1970-11-10 Upjohn Co Methylcellulose and polyalkylene glycol coating of solid medicinal dosage forms
IN158328B (de) * 1981-03-09 1986-10-18 Ici Plc
JPS58152813A (ja) * 1982-03-08 1983-09-10 Sumitomo Chem Co Ltd 鮮明な刻印を有する錠剤およびその製法
JPS58192819A (ja) * 1982-05-04 1983-11-10 Sumitomo Chem Co Ltd 鮮明な刻印を有する錠剤の製法
KR840000624A (ko) * 1982-06-02 1984-02-25 원본미기재 부식억제 페인트 조성물
EP0096982B1 (de) * 1982-06-10 1987-09-16 Imperial Chemical Industries Plc Herstellung von deutlich vertieft geprägten Gegenständen
FR2548675B1 (fr) * 1983-07-06 1987-01-09 Seppic Sa Compositions filmogenes pour enrobage des formes solides de produits pharmaceutiques ou alimentaires et produits obtenus revetus desdites compositions
US4576646A (en) * 1983-07-06 1986-03-18 Seppic Film-forming compositions for enveloping solid forms, particularly pharmaceutical or food products or seeds, and products obtained, coated with said compositions
US5006362A (en) * 1988-05-09 1991-04-09 Berwind Pharmaceutical Services, Inc. Branding pharmaceutical dosage forms, food and confectionery products with aqueous ingestible inks
US5098715A (en) * 1990-12-20 1992-03-24 Burroughs Wellcome Co. Flavored film-coated tablet

Also Published As

Publication number Publication date
JPH06504935A (ja) 1994-06-09
IE75729B1 (en) 1997-09-24
IE920611A1 (en) 1992-09-09
EP0573462A1 (de) 1993-12-15
ES2094902T3 (es) 1997-02-01
DK0573462T3 (da) 1996-11-11
AU1260392A (en) 1992-10-06
GR3021929T3 (en) 1997-03-31
US5405642A (en) 1995-04-11
ZA921428B (en) 1993-08-26
WO1992015288A1 (en) 1992-09-17
EP0501553A1 (de) 1992-09-02
CA2104096A1 (en) 1992-08-28
CA2104096C (en) 2003-06-10
JP3237758B2 (ja) 2001-12-10
DE69214130T2 (de) 1997-02-06
MX9200831A (es) 1992-08-01
TW201697B (de) 1993-03-11
NZ241613A (en) 1993-06-25
EP0573462B1 (de) 1996-09-25
DE69214130D1 (de) 1996-10-31

Similar Documents

Publication Publication Date Title
ATE143259T1 (de) Verfahren zum hervorheben von prägungen in tabletten
DE59003545D1 (de) Verfahren zum Färben von Polyamidsubstraten.
DE69005926D1 (de) Verfahren zum Beschichten von Titandioxidpigmenten.
DE69630373D1 (de) Verfahren zum etikettieren von behältern
DE59201211D1 (de) Verfahren zum Einfärben von Baustoffen.
DE69201913D1 (de) Verfahren zum Trocknen von Gegenständen.
DE69206409D1 (de) Verbessertes verfahren zum überziehen von alkylketendimeren auf titaniumdioxid.
ATA71390A (de) Verfahren zur qualitaetskontrolle von verpackten, organischen stoffen, sowie ein verpackungsmaterial zur durchfuehrung des verfahrens
DE69604962D1 (de) Verfahren zum Anbringen von Hydrogel-Überzügen auf embryonale Pflanzen
DE69301060D1 (de) Verfahren zum Aufbringen von Lot
DE59203797D1 (de) Verfahren zum Einfärben von Baustoffen.
DE69331887D1 (de) Verfahren zum Lernen von Mustern
DE59100238D1 (de) Verfahren zum beschichten von schaufeln.
DE59105433D1 (de) Verfahren zum Einfärben von Baustoffen.
DE69009138D1 (de) Verfahren zur Vorbeugung von Farbwechsel bei Nahrungsmitteln.
DE59404793D1 (de) Verfahren zum trocken von automobillacken
DE69205482D1 (de) Verfahren zum Verpacken von Gegenständen.
EP0584710A3 (de) Verfahren zum Bleichen von Textilien.
DE58907371D1 (de) Verfahren zum Färben von synthetischen Fasermaterialien.
DE69110232D1 (de) Verfahren zum färben von polymeren.
DE69314644D1 (de) Verfahren zur isomerisierung von 1,1,2-trichlortrifluorethan
DE59106470D1 (de) Verfahren zum Einfärben von Baustoffen.
ATE120181T1 (de) Verfahren zum behandeln von amiden.
DE69422888D1 (de) Verfahren zum Dispergieren von Pigmenten
DE59003396D1 (de) Verfahren zum Färben von Papier.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification